ArticleJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2025
Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.
Article in Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We measured anti-S immunoglobulin G (IgG) levels in a cohort of health care workers (HCWs) to explore factors affecting the levels of vaccine-induced IgG antibodies and their relationship with risk of incident SARS-CoV-2 infection throughout the first seven epidemic waves. Methods: A convenience sample of HCWs from one acute care hospital and four long-term care homes had anti-S SARS-CoV-2 IgG antibody levels at the beginning of the pandemic (T1) and during Omicron waves 5-7 (T2). Poisson analysis was conducted to assess predicted levels of antibodies by covariates (health and social conditions), number, timing and type of vaccines, as well as history of previous SARS-CoV-2 infection. Antibody levels assessed between October 2021 and August 2022 were also analyzed in relation to incident cases of Omicron infections. Results: Of the HCWs who provided one (n = 128) or two blood samples (n = 146), 53% were vaccine naïve at T1 and 1.4% were so at T2. The mean SARS-CoV-2 IgG concentration was 648 binding antibody units/mL at T1 and 1,913 binding antibody units/mL at T2. Income insufficiency and the presence of more than one chronic condition were associated with lower antibody levels at T2. Antibody levels were higher in HCWs with prior SARS-CoV-2 infection and increased with more vaccine doses received. Hybrid immunity elicited higher levels of antibodies in HCWs at T1 and T2. Waning of antibody levels over time was seen after vaccination with a third dose at T2. A correlation between antibody levels and subsequent risk of Omicron infection was not found. Conclusions: Our results suggest that timing and prioritization of anti-SARS-CoV-2 vaccination needs to consider the health and socioeconomic factors of HCWs, and the waning effects of vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.